• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[动物模型在缺氧相关疾病研究中的应用]

[Application of Animal Models in Research on Hypoxia-Related Diseases].

作者信息

Xu Yifan, Zhou Chenchen, Liu Xicheng, Guo Weihua, Zhou Jian

机构信息

( 100070) Department of Dental Implant Center, Beijing Stomatological Hospital, Capital Medical University, Beijing 100070, China.

( 610041) State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):331-338. doi: 10.12182/20250360101.

DOI:10.12182/20250360101
PMID:40599265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12207023/
Abstract

Hypoxia-related diseases, such as altitude sickness, acute lung injury, and heart failure, have emerged as significant public health challenges worldwide and are strongly associated with increased mortality risks. These conditions tend to cause functional impairment and structural alterations in multiple organs, primarily due to inadequate oxygen supply or the inability of tissues to utilize oxygen effectively. To elucidate the pathophysiological mechanisms underlying hypoxia-associated diseases and to explore potential therapeutic strategies, researchers have employed animal models to conduct extensive mechanistic studies and drug development trials. In this review, we provide a comprehensive overview of the methods used to construct animal models for various hypoxia-related diseases. We made a thorough evaluation of the strengths, weaknesses, limitations, and applicability of each approach. In particular, we focus on modeling strategies for key pathologies such as altitude sickness, acute lung injury, pulmonary hypertension, and heart failure, discussing their respective advantages and restrains. Furthermore, we examined the potential application of gene editing technologies in optimizing animal models, especially its role in enhancing the accuracy and reproducibility of the models. The integration of these advanced technologies holds great promise for developing animal models with improved specificity and simulation of key features of diseases, which will serve as a solid foundation for basic research, drug screening, and preclinical trials concerning hypoxia-related diseases. Herein, we present a systematic summary and future outlook of animal models for hypoxia-related diseases, ultimately providing theoretical support for developing clinical treatment strategies and improving patient outcomes.

摘要

缺氧相关疾病,如高原病、急性肺损伤和心力衰竭,已成为全球重大的公共卫生挑战,并与死亡率增加密切相关。这些疾病往往会导致多个器官的功能障碍和结构改变,主要是由于氧气供应不足或组织无法有效利用氧气。为了阐明缺氧相关疾病的病理生理机制并探索潜在的治疗策略,研究人员采用动物模型进行了广泛的机制研究和药物开发试验。在本综述中,我们全面概述了用于构建各种缺氧相关疾病动物模型的方法。我们对每种方法的优点、缺点、局限性和适用性进行了全面评估。特别是,我们重点关注高原病、急性肺损伤、肺动脉高压和心力衰竭等关键病理的建模策略,讨论它们各自的优点和限制。此外,我们研究了基因编辑技术在优化动物模型中的潜在应用,尤其是其在提高模型准确性和可重复性方面的作用。这些先进技术的整合有望开发出具有更高特异性和模拟疾病关键特征的动物模型,这将为缺氧相关疾病的基础研究、药物筛选和临床试验奠定坚实基础。在此,我们对缺氧相关疾病的动物模型进行系统总结和展望,最终为制定临床治疗策略和改善患者预后提供理论支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b30/12207023/49c5f928ecfd/scdxxbyxb-56-2-331-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b30/12207023/49c5f928ecfd/scdxxbyxb-56-2-331-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b30/12207023/49c5f928ecfd/scdxxbyxb-56-2-331-1.jpg

相似文献

1
[Application of Animal Models in Research on Hypoxia-Related Diseases].[动物模型在缺氧相关疾病研究中的应用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):331-338. doi: 10.12182/20250360101.
2
Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.预防高原病的干预措施:第2部分。较少使用的药物。
Cochrane Database Syst Rev. 2018 Mar 12;3(3):CD012983. doi: 10.1002/14651858.CD012983.
3
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
4
Interventions for treating acute high altitude illness.治疗急性高原病的干预措施。
Cochrane Database Syst Rev. 2018 Jun 30;6(6):CD009567. doi: 10.1002/14651858.CD009567.pub2.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.成人慢性未抑制的HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
8
Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.预防高原病的干预措施:第1部分。常用药物类别。
Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD009761. doi: 10.1002/14651858.CD009761.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.

本文引用的文献

1
Cardiomyocyte proliferation: Advances and insights in macrophage-targeted therapy for myocardial injury.心肌细胞增殖:针对心肌损伤的巨噬细胞靶向治疗的进展与见解
Genes Dis. 2024 May 19;12(3):101332. doi: 10.1016/j.gendis.2024.101332. eCollection 2025 May.
2
Multimodal Treatment of Sleep Apnea.睡眠呼吸暂停的多模式治疗
Sleep Med Clin. 2025 Mar;20(1):115-126. doi: 10.1016/j.jsmc.2024.10.006. Epub 2024 Dec 10.
3
Cyanide and Cyanogenic Compounds-Toxicity, Molecular Targets, and Therapeutic Agents.氰化物和生氰化合物——毒性、分子靶标和治疗剂。
Biomolecules. 2024 Nov 7;14(11):1420. doi: 10.3390/biom14111420.
4
Insights, recommendations, and research priorities for central sleep apnea: report from an expert panel.中枢性睡眠呼吸暂停的见解、建议及研究重点:专家小组报告
J Clin Sleep Med. 2025 Feb 1;21(2):405-416. doi: 10.5664/jcsm.11424.
5
Role of Nitric Oxide Synthases in Respiratory Health and Disease: Insights from Triple Nitric Oxide Synthases Knockout Mice.一氧化氮合酶在呼吸健康和疾病中的作用:三重一氧化氮合酶敲除小鼠的研究进展。
Int J Mol Sci. 2024 Aug 28;25(17):9317. doi: 10.3390/ijms25179317.
6
IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3-Led Ubiquitylation of GPX4.间歇性低氧诱导的巨噬细胞来源的白细胞介素 6 通过 MARCH3 介导的 GPX4 泛素化促进铁死亡加重非酒精性脂肪性肝病。
Adv Sci (Weinh). 2024 Nov;11(41):e2402241. doi: 10.1002/advs.202402241. Epub 2024 Sep 4.
7
Remote ischemic preconditioning prevents high-altitude cerebral edema by enhancing glucose metabolic reprogramming.远程缺血预处理通过增强葡萄糖代谢重编程预防高原脑水肿。
CNS Neurosci Ther. 2024 Sep;30(9):e70026. doi: 10.1111/cns.70026.
8
Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor.间充质干细胞衍生的微泡部分通过肝细胞生长因子抑制小鼠急性呼吸窘迫综合征相关的肺纤维化。
World J Stem Cells. 2024 Aug 26;16(8):811-823. doi: 10.4252/wjsc.v16.i8.811.
9
Aquaporin 1 confers apoptosis resistance in pulmonary arterial smooth muscle cells from the SU5416 hypoxia rat model.水通道蛋白 1 赋予 SU5416 低氧大鼠模型肺动脉平滑肌细胞抗凋亡能力。
Physiol Rep. 2024 Aug;12(16):e16156. doi: 10.14814/phy2.16156.
10
ELK4 ameliorates cognitive impairment and neuroinflammation induced by obstructive sleep apnea.ELK4 可改善阻塞性睡眠呼吸暂停引起的认知障碍和神经炎症。
Brain Res Bull. 2024 Oct 1;216:111054. doi: 10.1016/j.brainresbull.2024.111054. Epub 2024 Aug 20.